Recanalization and Reperfusion Therapies of Acute Ischemic Stroke: What have We Learned, What are the Major Research Questions, and Where are We Headed?

Two placebo-controlled trials have shown that early administration of intravenous recombinant tissue plasminogen activator (rt-PA) after ischemic stroke improves outcomes up to 4.5 h after symptoms onset; however, six other trials contradict these results. We also know from analysis of the pooled da...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomis, Meritxell, Dávalos, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237052/
https://www.ncbi.nlm.nih.gov/pubmed/25477857
http://dx.doi.org/10.3389/fneur.2014.00226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237052/
https://www.ncbi.nlm.nih.gov/pubmed/25477857
http://dx.doi.org/10.3389/fneur.2014.00226

Ejemplares similares